Mechanism of human somatic reprogramming to iPS cell.
Rika Teshigawara1, Junkwon Cho1, Masahiro Kameda1
1Department of Developmental Epigenome, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Summary
Understanding somatic reprogramming to induced pluripotent stem cells (iPSCs) is crucial. New methods visualize OCT4 activation, revealing key steps in human iPSC generation and paving the way for future research.
Area of Science:
- Stem cell biology
- Epigenetics
- Molecular mechanisms of reprogramming
Background:
- Somatic reprogramming to induced pluripotent stem cells (iPSCs) was first achieved in mice (2006) and humans (2007) using exogenous transcription factors.
- Human and mouse iPSCs exhibit distinct 'primed' and 'naïve' reprogramming states, respectively.
- Despite progress, the molecular mechanisms underlying human somatic reprogramming remain incompletely understood.
Purpose of the Study:
- To investigate the molecular events during human somatic reprogramming.
- To visualize and understand the timing of OCT4 activation and mesenchymal-to-epithelial transition (MET) during iPSC generation.
- To explore the utility of genome-editing technologies in studying reprogramming.
Main Methods:
- Establishment and culture of a human intermediately reprogrammed stem cell (iRSC) line.
- Utilizing genome-editing to create OCT4-GFP reporter iRSCs.
- Monitoring OCT4 activation and MET entry in real-time using live-cell imaging.
Main Results:
- An iRSC line was established, paused at a pre-MET stage, capable of resuming reprogramming into OCT4-positive iPSCs upon culture condition changes.
- Genome-editing enabled real-time visualization of endogenous OCT4 activation and its correlation with MET entry.
- This visualization precisely demonstrated the temporal dynamics of key reprogramming events.
Conclusions:
- Human somatic reprogramming is a complex process that can be dissected using advanced stem cell models and genome-editing tools.
- The timing of OCT4 activation and MET is a critical determinant in successful iPSC generation.
- Genome-editing applications offer powerful new avenues for elucidating the molecular intricacies of pluripotency and reprogramming.
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
01:32Chromatin Modification in iPS Cells
2.2K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.2K
01:24Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
01:22iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
01:06Induced Pluripotent Stem Cells
5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.7K
01:13Induced Pluripotent Stem Cells
28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K